Alnylam Pharmaceuticals | Créances Commerciales



Trade Debtors Changement Date
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Agios Pharmaceuticals USD 4.11M 991K 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Amgen USD 6.78B 535M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Incyte USD 853.15M 94.7M 2024-12
Ionis Pharmaceuticals USD 92.19M 74.26M 2024-12
Moderna USD 592M 1.24B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 7.56B 594M 2024-12
PTC Therapeutics USD 158.55M 41.42M 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Sanofi 10.63B 1.82B 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Takeda JPY 735.06B 14.01B 2024-12
Tectonic Therapeutic USD 0 270K 2023-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12
Xencor USD 60.85M 50.64M 2024-12



Alnylam Pharmaceuticals Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.